Related Experiment Videos

New therapeutic agents targeting the epidermal growth factor receptor

¹Vall d'Hebron Hospital, Barcelona, Spain.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

|November 4, 2000

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Are we assuming too much with our statistical assumptions? Lessons learned from the ALTTO trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2019

RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2018

The use of breast imaging for predicting response to neoadjuvant lapatinib, trastuzumab and their combination in HER2-positive breast cancer: Results from Neo-ALTTO.

European journal of cancer (Oxford, England : 1990)·2017

Oncologist use and perception of large panel next-generation tumor sequencing.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

See all related articles